Marshall Wace North America’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $282K | Buy |
+26,362
| New | +$282K | ﹤0.01% | 1208 |
|
2019
Q2 | – | Sell |
-4,522
| Closed | -$111K | – | 1338 |
|
2019
Q1 | $111K | Sell |
4,522
-6,815
| -60% | -$167K | ﹤0.01% | 1096 |
|
2018
Q4 | $294K | Buy |
+11,337
| New | +$294K | ﹤0.01% | 892 |
|
2018
Q3 | – | Sell |
-156,298
| Closed | -$6.07M | – | 1109 |
|
2018
Q2 | $6.07M | Buy |
+156,298
| New | +$6.07M | 0.03% | 466 |
|